CLINICAL_TRIALS trial_result · 2018-04-20

Clinical Trial Update: A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus [Phase 3]

Phase 3 trial update for LY2605541 in adults with Type 2 diabetes mellitus; the study has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-04-20